The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of CDK4 amplification with duration of response to bevacizumab in glioblastoma.
 
John L. Villano
No Relationships to Disclose
 
Rachael M Morgan
No Relationships to Disclose
 
Shulin Zhang
No Relationships to Disclose
 
Jill Kolesar
Stock and Other Ownership Interests - Helix Diagnostics
Consulting or Advisory Role - The Jackson Laboratory
Research Funding - ArtemiLife; Loxo/Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for a cell based therapy derived from human macrophages
Travel, Accommodations, Expenses - Caris Life Sciences
 
Joanne Xiu
Employment - Caris Life Sciences
 
Hilary Seifert
Employment - Caris Life Sciences
 
Theodore Nicolaides
Employment - Caris Life Sciences
 
Stephanie Rock
No Relationships to Disclose
 
Santosh Kesari
Leadership - Curtana
Stock and Other Ownership Interests - Curtana; Nascent Biotech
Consulting or Advisory Role - Biocept; Curtana; iCAD; Partners Therapeutics; xCures
Research Funding - Acrotech Biopharma; AIVITA Biomedical, Inc.; Bavarian Nordic; Biocept; Boehringer Ingelheim; Caris Life Sciences; Chimerix; CNS Pharmaceuticals; EIP Pharma; EpicentRx; iCAD; Novocure; Oblato; Orbus Therapeutics; Stemedica Cell Technologies; Tempus
 
Sonikpreet Aulakh
No Relationships to Disclose
 
Eric T. Wong
Honoraria - Advanced Medical; Novocure; UpToDate; Zai Lab
Consulting or Advisory Role - Turning Point Therapeutics
Research Funding - Five Prime Therapeutics; Novocure (Inst); Oblato (Inst); Orbus Therapeutics (Inst)
 
Michael J. Glantz
Research Funding - cns pharmaceuticals (Inst); Denovo Biopharma (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmunoCellular Therapeutics (Inst); Ono Pharmaceutical (Inst); RTOG (Inst); Triphase Accelerator Corp (Inst)